139 related articles for article (PubMed ID: 8131686)
1. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.
López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686
[TBL] [Abstract][Full Text] [Related]
2. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
[TBL] [Abstract][Full Text] [Related]
3. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
Fischbach W; Deubel M; Boege F; Mössner J
Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
[TBL] [Abstract][Full Text] [Related]
4. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
Schwery S; Meyenberger C; Ammann R; Wirth HP
Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
[TBL] [Abstract][Full Text] [Related]
5. Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum.
Biancone L; Fantini M; Tosti C; Bozzi R; Vavassori P; Pallone F
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):261-6. PubMed ID: 12610321
[TBL] [Abstract][Full Text] [Related]
6. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
Boege F; Fischbach W
Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
[TBL] [Abstract][Full Text] [Related]
7. Characterization and evaluation of immunochemical methods for the measurement of fecal alpha 1-antitrypsin.
Buffone GJ; Shulman RJ
Am J Clin Pathol; 1985 Mar; 83(3):326-30. PubMed ID: 3919562
[TBL] [Abstract][Full Text] [Related]
8. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
[TBL] [Abstract][Full Text] [Related]
9. Fecal alpha1--antitrypsin in healthy and intestinal-disorder Thai children.
Tangsilsat D; Atamasirikul K; Treepongkaruna S; Bed SN; Sumritsopak R; Kunakorn M
J Med Assoc Thai; 2007 Jul; 90(7):1317-22. PubMed ID: 17710971
[TBL] [Abstract][Full Text] [Related]
10. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
[TBL] [Abstract][Full Text] [Related]
11. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease.
Grill BB; Hillemeier AC; Gryboski JD
J Pediatr Gastroenterol Nutr; 1984; 3(1):56-61. PubMed ID: 6607330
[TBL] [Abstract][Full Text] [Related]
12. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
Thomas DW; Sinatra FR; Merritt RJ
J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
[TBL] [Abstract][Full Text] [Related]
13. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
Hundegger K; Stufler M; Karbach U
Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
[TBL] [Abstract][Full Text] [Related]
14. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
[TBL] [Abstract][Full Text] [Related]
15. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
Karbach U; Singe CC; Ewe K
Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
[TBL] [Abstract][Full Text] [Related]
17. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
18. A new automated turbidimetric immunoassay for quantifying alpha 1-antitrypsin in serum.
Viedma JA; de la Iglesia A; Parera M; López MT
Clin Chem; 1986 Jun; 32(6):1020-2. PubMed ID: 3085977
[TBL] [Abstract][Full Text] [Related]
19. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
Duarte MA; Carneiro SM; Melo MC; Penna FJ
Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
[TBL] [Abstract][Full Text] [Related]
20. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces.
van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A
AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
